Wickerham;DL;Anderson;SA;Fisher;B;et;al.NSABP Protocol B-06:A randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer-results after15years of fol-low-up.European Journal of Cancer.1998...
5 1958---Thefirstpatientwasenrolledinthefirst randomizedclinicaltrialundertakenby23researchers fromparticipatingsitesthroughouttheUnitedStates.1967—Dr.BernardFisherwasappointedthe chairmanoftheSurgicalAdjuvantChemotherapy BreastProject.NoonecouldhaveforeseentheNSABP’slongevityanditsimpactonthetreatmentof breastcancer ...
Julian,Thomas B. Julian,Atif J. Kahn,Atif J. Kahn 展开 摘要: This phase III randomized post-NC trial will evaluate if CWRNRT after mastectomy (Mx) or whole breast irradiation (WBI) with RNRT after breast-conserving surgery (BCS) significantly reduces the rate of IBCR-FI in pts who ...
(2013) NSABP B-47: a randomized phase III trial of adjuvant therapy comparing chemotherapy alone to chemotherapy plus trastuzumab in women with node-... L Fehrenbacher,JH Jeong,P Rastogi,... - 《Cancer Research》 被引量: 14发表: 2011年 NSABP B-47/NRG Oncology Phase III Randomized Trial ...
In the NSABP DCIS trial B-24, the 10-year rate of ipsilateral invasive breast tumors was only 6%.41 The CORE results through 8 years of follow-up show that raloxifene continues to offer a significant reduction in invasive disease, suggesting that raloxifene has a durable benefit despite this ...
Cardiac safety analysis of the first stage of NSABP B-31, a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) to that of AC followed by paclitaxel plus trastuzumab (TH) in patients (pts) with operable, node-positive (N+),...
“We are pleased to have contributed to the NSABP B-42 trial findings, with the important observation that genomic profiling with MammaPrint identifies the cohort most likely to benefit from ELT, and those who are unlikely to benefit,” said William Audeh, MD, Chief Medical Officer at Agendia...
Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer...
Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31,聽a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2閳ユ彋ositive Breast ...
Fisher B Anderson S Redmond CK . Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer . N Engl J Med . 1995 Nov 30; 333 : 1456 – 61 ....